Stocks / Pharmaceuticals
CLDXPharmaceuticals
Celldex Therapeutics, Inc
$38.981d +0.7%5d +2.3%settled close · 2026-09-17
Mkt cap $2.1B (3/25)β 1.4152w $22–45Shares 66.6MInd. In Vitro & In Vivo Diagnostic SubstancesNasdaq since 1986Emp. 198HQ Hampton, NJcelldex.com
Who’s talkingIdea Scout · free
Who’s talking about CLDX
No tracked investor commentary on CLDX yet — the corpus grows weekly.
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
Earnings
Next report: 9 Nov 2026
Confirmed date · consensus EPS -1.04. Reactions below are the next settled session over the prior close.
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where CLDX’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 34 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-17 | ||||||
| 2026-09-14 | ||||||
| 2026-09-11 | ||||||
| 2026-09-10 | ||||||
| 2026-09-08 | ||||||
| 2026-09-04 | ||||||
| 2026-09-03 | ||||||
| 2026-09-01 | ||||||
| 2026-08-19 | ||||||
| 2026-08-13 | ||||||
| 2026-07-22 | ||||||
| 2026-07-21 | ||||||
| 2026-07-13 | ||||||
| 2026-07-08 | ||||||
| 2026-06-29 | ||||||
| 2026-06-25 | ||||||
| 2026-06-16 | ||||||
| 2026-05-12 | ||||||
| 2026-05-11 | ||||||
| 2026-05-07 | ||||||
| 2026-05-06 | ||||||
| 2026-05-05 | ||||||
| 2026-05-01 | ||||||
| 2026-04-30 | ||||||
| 2026-04-29 | ||||||
| 2026-04-28 | ||||||
| 2026-04-27 | ||||||
| 2026-04-24 | ||||||
| 2026-04-23 | ||||||
| 2026-04-22 | ||||||
| 2026-04-21 | ||||||
| 2026-04-20 | ||||||
| 2026-03-31 | ||||||
| 2026-03-27 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
CLDX is in this morning’s Brief.
Get The Brief — $20/mo →